(Updated - September 17, 2025 4:37 AM EDT)

Barclays analyst Etzer Darout initiates coverage on CytomX Therapeutics (NASDAQ: CTMX) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE